By Kevin Boyd CONSUMER HEALTH INTERACTIVEBelow: • What is the prostate, and how common is the cancer? • How can I prevent prostate cancer? • What are the symptoms? • Can my doctor test for prostate cancer? • If the biopsy shows cancer, is there a way to find out if it's the dangerous, fast-growing kind? • What are my treatment options? • What are the risks of aggressive treatment? • What's being done to improve detection and treatment?
What is the prostate, and how common is the cancer? It's a walnut-size gland that lies at the base of the bladder and surrounds the urethra. In the United States prostate cancer is one of the two most frequently diagnosed cancers in men (the other is skin cancer), accounting for 10 percent of cancer-related deaths in men. The American Cancer Society estimates that one man in 6 will be diagnosed with prostate cancer during his lifetime. However, only about one in 35 will die from the disease. Risk increases with age. Men 65 or older account for two-thirds of the cases diagnosed. African American men appear to be at greater risk than white men, and an individual's odds may be higher than average if the disease runs in his family. How can I prevent prostate cancer? For starters, load up on tomato sauce. Researchers at Harvard University found that men who ate cooked tomatoes or foods made with them (tomato sauce or ketchup, for instance) more than twice a week were less likely to develop prostate cancer. Tomatoes are particularly rich in the antioxidant lycopene. (An antioxidant is a substance that can neutralize unstable molecules which may trigger cancer.) Lycopene may have particular power to stop healthy prostate cells from turning malignant. (Since cooking tomatoes releases lycopene more thoroughly, tomato sauce offers better protection than fresh tomatoes.) Eat lots of other fruits and vegetables as well; they contain other natural antioxidants thought to guard against many forms of cancer. Cutting back on saturated fat -- the kind found in meat, dairy products, and most pastries -- is a good idea, too. A study funded by the National Cancer Institute showed that prostate cancer was linked to diets high in this type of fat. Some studies also suggest that regular physical activity may lower the risks of all types of cancer, including the kind that develops in the prostate. What are the symptoms? In early stages, prostate cancer generally has no symptoms, so most cases are detected by screening tests. Some men do notice that they have to urinate more often or that their stream of urine is weaker. But those changes can also arise from a less serious condition like an enlarged prostate. Advanced prostate cancer may result in swollen lymph nodes in the groin, problems maintaining an erection, and pain in the groin area, spine, hips, or ribs. If you have any of these symptoms, see your doctor. Can my doctor test for prostate cancer? Yes. He or she will use two basic screening methods. Neither is perfect; both have high false-positive rates, meaning that they frequently indicate cancer when there is none. The tests may also detect slow-growing tumors that will never get large enough to harm you. But both tests can help doctors identify cancer early enough to save your life. One is known as a digital rectal examination (DRE), in which your doctor checks for lumps or other abnormalities by feeling your prostate with a gloved finger. The other is a blood test called the prostate-specific antigen test (PSA) which measures a substance that typically increases in men when they have prostate cancer. If the PSA test is high (for a man over 50, a score of 4 or higher), or has risen compared with a previous test, your doctor may do a biopsy on your prostate tissue. The sample will then be examined for cancerous cells. Unfortunately, PSA levels can be misleading. According to a report in the May 2004 New England Journal of Medicine, 15 percent of a group of 2,950 men with normal PSA levels were still found to have prostate cancer. If the biopsy shows cancer, is there a way to find out if it's the dangerous, fast-growing kind? Doctors use a method called the Gleason system to estimate how aggressive a prostate cancer may be. Malignant cells are examined under a microscope and graded on a scale of 1 to 10 according to how different they look from normal cells. The Gleason score is far from conclusive; still, the higher the score, the more likely the cancer will grow and spread rapidly. Doctors may also look at changes in your PSA level over time to gauge the cancer's aggressiveness. What are my treatment options? Treatment depends on how far the cancer has advanced. If tumor cells are found only in the prostate itself, doctors may remove your prostate or use radiation therapy to kill the cells. A newer treatment involves embedding tiny radioactive seeds in the prostate. If the cancer has spilled out of the prostate gland into surrounding tissue, hormone therapy in the form of pills, shots, or both can slow the growth of malignant cells, sometimes dramatically so. Some patients choose to do nothing, an approach called "watchful waiting." This may sound alarming, but it may make sense, particularly for older men whose tumors are most likely to be slow growing. The majority of men who reach age 85, in fact, have cancerous prostate cells, but the disease is developing so gradually that it never threatens their quality of life. If conventional treatments aren't working, and you want to try herbs, talk to your doctor about your choices. In May 1999, researchers at the University of California at San Francisco released findings that indicated PC-SPES, a cocktail of eight traditional Chinese herbs that includes saw palmetto and licorice, retarded the growth of advanced prostate cancer. But in February 2002, PC-SPES ran afoul of authorities after tests by the California Department of Health Services turned up traces of warfarin, a prescription blood thinner that can raise the risk of serious bleeding. Subsequent tests found that some batches of PC-SPES contained other prescription medicines as well. BotanicLab Inc., the company that made PC-SPES, voluntarily recalled the product nationwide and it is no longer being made. The National Center for Complementary and Alternative Medicine (NCCAM) announced plans to study PC-SPES and its effect on prostate cancer once a standard product is available. The California Department of Health Services urged anyone using PC-SPES to stop taking the product immediately and seek medical advice. What are the risks of aggressive treatment? The biggest worries men face are losing their ability to get an erection or to control their bladder. Unfortunately, surgery and radiation entail some danger of both. Your own odds are difficult to calculate precisely, since the risk of these side effects depends on your age, the extent of the disease, and the type of surgery performed. A surgical nerve-sparing technique, introduced in the 1980s, has reduced the incidence of impotence, but it's not appropriate for all men. And the troubling fact remains that between 65 and 90 percent of patients whose prostates are removed suffer some inability to maintain an erection. A smaller percentage lose some degree of bladder control. Others may experience occasional urinary dribbling when they exert themselves or cough. Talk to your doctor about the best ways to deal with these problems. What's being done to improve detection and treatment? Plenty. The National Cancer Institute is funding studies on a wide variety of new treatments, including hormones that block the growth of tumor cells and substances that cut off a tumor's blood supply. Researchers are also looking for better ways to distinguish between slow-growing and fast-growing prostate cancers. -- Kevin Boyd, formerly a freelance health reporter, now works in the communications department at UCSF Medical School in San Francisco, California.
Further Resources National Cancer Institute American Cancer Society
References Giovannucci, Edward et al, "A Prospective Study of Tomato Products, Lycopene, and Prostate Cancer Risk", JNCI, Vol. 94, No. 5, 391-398, March 6, 2002
Adolfsson J, Steineck G, et al. Recent results of management of palpable clinically localized prostrate cancer. Cancer 1993;72:310-322.
Coley CM, Barry MJ, Fleming C, et al.: Early detection of prostrate cancer: part II: Annals of Internal Medicine 126(6): 468-479, 1997.
Chan EC, Sulmasy DP: What should men know about prostrate-specific antigen screening before giving informed consent? American Journal of Medicine 105(4): 226-274: 1998.
Chodak GW, Thisted RA, et al. results of conservative management of clinically localized prostrate cancer. N Engl J Med 1994;330:242-248.
Denis LJ: Prostrate cancer screening and prevention: "realities and hope". Urology 46(Suppl 3A): 56-61, 1995.
Schroder FH, Bangma CH: The European ramdomized study of screening for prostrate cancer(ERSPC). British Journal of Erology 79(Suppl 1):68-71, 1997.
Screening for prostate cancer in American men. American College of Preventive Medicine. 1998
California Department of Health Services. State health director warns consumers about prescription drugs in herbal products. February 7, 2002.
BotanicLab Pursues Investigation of "Compound" Found In PC SPES, Business Wire, Feb. 20, 2002
Thompson IM, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level less than or equal to 4.0 ng per milliliter. N Engl J Med 350:2239-2246. May 27, 2004
Prostate Cancer. Medline Plus. http://www.nlm.nih.gov/medlineplus/ency/article/000380.htm
American Cancer Society. What Are Key Statistics About Prostate Cancer? July 2006. http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics_for_prostate_cancer_36.asp?sitearea=
American Cancer Society. How Many Men Get Prostate Cancer? June 2007. http://www.cancer.org/docroot/CRI/content/CRI_2_2_1X_How_many_men_get_prostate_cancer_36.asp?sitearea=
American Cancer Society. What Causes Prostate Cancer? May 2006. http://www.cancer.org/docroot/CRI/content/CRI_2_2_2X_What_causes_prostate_cancer_36.asp?sitearea=
University of Pittsburgh Medical Center, Cancer Centers. Prostate Cancer: Erectile Dysfunction. July 2006. http://www.upmccancercenters.com/cancer/prostate/erectiledysfunction.html
National Cancer Institute. Questions and Answers about PC-SPES. Sept 2007. http://www.cancer.gov/cancertopics/pdq/cam/pc-spes/Patient/15.cdr#Section_15
Reviewed by Bruce Biller, M.D., director of the Harvard Business School Health Services and a board-certified internist with subspecialty training in endocrinology.
First published June 1, 1999
Last updated March 12, 2008
Copyright © 1999 Consumer Health Interactive
|